AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Exosomes as a Novel Therapy for Fibrosis

Detailed Technology Description
Researchers at Nationwide Children’s Hospital have found that exosomes from healthy cells contain molecular signals reflective of a healthy state and can be delivered to fibrotic cells that mitigate or reverse fibrosis.
Countries
United States
Application No.
62/057,971
*Abstract

Fibrosis (chronic scarring) accounts for up to 45% of deaths in thedeveloped world, but there are no FDA-approved anti-fibrotic therapies.Researchers at Nationwide Children’s Hospital have found that exosomes fromhealthy cells contain molecular signals reflective of a healthy state and canbe delivered to fibrotic cells that mitigate or reverse fibrosis. This noveltherapy will have an impact on numerous diseases, including liver disease,cardiovascular disease, pulmonary fibrosis, kidney disease, and maculardegeneration.

*Inquiry
Kyle Murrah, Ph.D.The Research Institute at Nationwide Children's HospitalOffice of Technology Commercialization700 Children's Drive Columbus OH 43205T: 614 355-4551 F: 614 722-2716Kyle.Murrah@nationwidechildrens.org
*IP Issue Date
None
*IP Type
Provisional
Country/Region
USA

For more information, please click Here
Mobile Device